Viewing Study NCT02287558


Ignite Creation Date: 2025-12-25 @ 12:20 AM
Ignite Modification Date: 2025-12-25 @ 10:24 PM
Study NCT ID: NCT02287558
Status: COMPLETED
Last Update Posted: 2020-07-15
First Post: 2014-11-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study
Sponsor: The Cleveland Clinic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module